BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22014607)

  • 1. Widespread cerebral cortical mineralization in Wilson's disease detected by susceptibility-weighted imaging.
    Lee JH; Yang TI; Cho M; Yoon KT; Baik SK; Han YH
    J Neurol Sci; 2012 Feb; 313(1-2):54-6. PubMed ID: 22014607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wilson's disease: demonstration of lesions of the cortex and white matter by MRI].
    Le Fort D; Deleplanque B; Louiset P; Pautrizel B; Loiseau P
    Rev Neurol (Paris); 1988; 144(5):365-7. PubMed ID: 3420353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cranial MR imaging in Wilson's disease.
    King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
    AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive cortico-subcortical lesions in Wilson's disease: clinico-pathological study of two cases.
    Mikol J; Vital C; Wassef M; Chappuis P; Poupon J; Lecharpentier M; Woimant F
    Acta Neuropathol; 2005 Nov; 110(5):451-8. PubMed ID: 16195917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral magnetic resonance in Wilson's disease].
    Amato C; Bisceglie P; Moschini M
    Radiol Med; 1994 Dec; 88(6):752-7. PubMed ID: 7878232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease with myoclonus and white matter lesions.
    Barbosa ER; Silveira-Moriyama L; Machado AC; Bacheschi LA; Rosemberg S; Scaff M
    Parkinsonism Relat Disord; 2007 Apr; 13(3):185-8. PubMed ID: 16740400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of epilepsy in Wilson's disease with electroencephalographic, MR imaging and pathological correlates.
    Prashanth LK; Sinha S; Taly AB; A Mahadevan ; Vasudev MK; Shankar SK
    J Neurol Sci; 2010 Apr; 291(1-2):44-51. PubMed ID: 20116809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Wilson's disease: computed tomography and magnetic resonance imaging].
    Tejada J; Barreiro P; Díez Tejedor E; Frank A
    Neurologia; 1990 Nov; 5(9):328-31. PubMed ID: 2100134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structures.
    Südmeyer M; Saleh A; Wojtecki L; Cohnen M; Gross J; Ploner M; Hefter H; Timmermann L; Schnitzler A
    Mov Disord; 2006 Dec; 21(12):2134-9. PubMed ID: 17044091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of cerebral water diffusion in Wilson disease.
    Favrole P; Chabriat H; Guichard JP; Woimant F
    Neurology; 2006 Feb; 66(3):384-9. PubMed ID: 16476937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease.
    Bai X; Wang G; Wu L; Liu Y; Cui L; Shi H; Guo L
    Pediatr Res; 2014 Mar; 75(3):436-42. PubMed ID: 24477071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent akinetic-rigid side effects of neuroleptics may indicate Wilson's disease.
    Aschermann Z; Szalay F; Schmidt E; Komoly S; Illés Z
    Ideggyogy Sz; 2007 Sep; 60(9-10):404-5. PubMed ID: 17987735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of diffusion weighted magnetic resonance imaging in Wilson's disease].
    Kishibayashi J; Segawa F; Kamada K; Sunohara N
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1086-9. PubMed ID: 8293612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High field magnetic resonance imaging in Wilson's disease].
    Hitoshi S; Nangaku M; Shimada H; Yamada H; Yoshikawa H; Iwata M
    Rinsho Shinkeigaku; 1990 Feb; 30(2):139-45. PubMed ID: 2350924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of nodular liver lesions in Wilson's disease.
    Kozic D; Svetel M; Petrovic I; Sener RN; Kostic VS
    Acta Radiol; 2006 Sep; 47(7):624-7. PubMed ID: 16950693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging.
    Wang A; Wu H; Xu C; Tang L; Lee J; Wang M; Jiang M; Li C; Lu Q; Zhang C
    Neural Plast; 2017; 2017():7323121. PubMed ID: 28781902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
    Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
    PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up.
    Larnaout A; Ammar N; Mourad Z; Naji S; Hentati F
    Neuropediatrics; 2008 Jun; 39(3):176-8. PubMed ID: 18991198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical gray matter lesions in acute encephalopathy with febrile convulsive status epilepticus.
    Sato A; Mizuguchi M; Mimaki M; Takahashi K; Jimi H; Oka A; Igarashi T
    Brain Dev; 2009 Sep; 31(8):622-4. PubMed ID: 18848752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.